Teladoc (TDOC) Stock Forecast & Price Target

Compare

12,014 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TDOC Analyst Ratings

Hold

2 Buy

13 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Teladoc

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TDOC Stock 12 Month Forecast

Average Price Target

$8.79

▲(18.78%Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Teladoc in the last 3 months. The average price target is $8.79 with a high forecast of $12.00 and a low forecast of $7.00. The average price target represents a 18.78% change from the last price of $7.40.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","7":"$7","9":"$9","11":"$11","13":"$13"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$12.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.79</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,7,9,11,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.58,8.843076923076923,9.106153846153846,9.36923076923077,9.632307692307693,9.895384615384616,10.15846153846154,10.42153846153846,10.684615384615384,10.947692307692307,11.21076923076923,11.473846153846154,11.736923076923077,{"y":12,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.58,8.596153846153847,8.612307692307692,8.628461538461538,8.644615384615385,8.66076923076923,8.676923076923076,8.693076923076923,8.70923076923077,8.725384615384614,8.741538461538461,8.757692307692308,8.773846153846153,{"y":8.79,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.58,8.458461538461538,8.336923076923076,8.215384615384615,8.093846153846155,7.972307692307693,7.850769230769231,7.729230769230769,7.607692307692307,7.486153846153846,7.364615384615385,7.243076923076924,7.121538461538462,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.32,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.59,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.17,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.86,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.21,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.5,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.09,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.16,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.56,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.76,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.99,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.87,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$12.00

Average Price Target$8.79

Lowest Price Target$7.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$7.5

Hold

1.35%

Upside

Reiterated

07/31/25

Teladoc's overall stock score is primarily impacted by financial performance issues, including negative profitability and high leverage. Technical analysis reflects weak momentum, further weighing down the score. Despite some positive notes from the earnings call, challenges in certain segments and a lack of appealing valuation metrics limit the overall score.

Ryan MacDonaldNeedham

Needham

―

Hold

―

Reiterated

07/30/25

Cautious Hold on Teladoc Amid Competitive Pressures and Strategic Risks

David GrossmanStifel Nicolaus

Stifel Nicolaus

Hold

8.11%

Upside

Reiterated

07/30/25

Stifel Nicolaus Sticks to Its Hold Rating for Teladoc (TDOC)

Michael ChernyLeerink Partners

Leerink Partners

$7.5

Hold

1.35%

Upside

Reiterated

07/30/25

Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures

Allen LutzBank of America Securities

Bank of America Securities

$8.75→$8.5

Hold

14.86%

Upside

Reiterated

07/30/25

Teladoc's Strategic Shift and Competitive Pressures Lead to Hold Rating

Charles RhyeeTD Cowen

TD Cowen

Hold

8.11%

Upside

Reiterated

07/30/25

Teladoc's Mixed Performance: Strong IC Growth Overshadowed by BH Segment Uncertainty Leading to Hold Rating

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

$7→$8

Hold

8.11%

Upside

Reiterated

07/30/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC), Ionis Pharmaceuticals (NASDAQ: IONS) and Repligen (NASDAQ: RGEN)

Jailendra SinghTruist Financial

Truist Financial

―

Hold

―

Reiterated

07/30/25

Teladoc (TDOC) Gets a Hold from Truist Financial

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$12→$10

Buy

35.14%

Upside

Reiterated

07/29/25

Teladoc price target lowered to $10 from $12 at Cantor FitzgeraldTeladoc price target lowered to $10 from $12 at Cantor Fitzgerald

Ryan DanielsWilliam Blair

William Blair

―

Hold

―

Reiterated

07/29/25

Teladoc's Transitional Phase: Balancing Growth Challenges and Strategic Opportunities

Daniel GrosslightCiti

Citi

$8→$9.5

Hold

28.38%

Upside

Reiterated

07/28/25

Citi Keeps Their Hold Rating on Teladoc (TDOC)

Steven ValiquetteMizuho Securities

Mizuho Securities

$10

Hold

35.14%

Upside

Initiated

07/25/25

Teladoc's Mixed Prospects: Hold Rating Amid Growth in Integrated Care and Challenges in BetterHelp Segment

Jessica TassanPiper Sandler

Piper Sandler

$12

Buy

62.16%

Upside

Reiterated

07/18/25

Teladoc (TDOC) Receives a Buy from Piper Sandler

Lisa GillJ.P. Morgan

J.P. Morgan

$11→$9

Hold

21.62%

Upside

Reiterated

05/16/25

Teladoc (TDOC) PT Lowered to $9 at JPMorganJPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $9.00 (from $11.00) while maintaining a Neutral rating.

Stephen BaxterWells Fargo

Wells Fargo

$10→$8

Hold

8.11%

Upside

Reiterated

05/08/25

Teladoc (TDOC) PT Lowered to $8 at Wells FargoWells Fargo analyst Stephen Baxter lowered the price target on Teladoc (NYSE: TDOC) to $8.00 (from $10.00) while maintaining a Equal Weight rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$7.5

Hold

1.35%

Upside

Reiterated

07/31/25

Ryan MacDonaldNeedham

Needham

―

Hold

―

Reiterated

07/30/25

Cautious Hold on Teladoc Amid Competitive Pressures and Strategic Risks

David GrossmanStifel Nicolaus

Stifel Nicolaus

Hold

8.11%

Upside

Reiterated

07/30/25

Stifel Nicolaus Sticks to Its Hold Rating for Teladoc (TDOC)

Michael ChernyLeerink Partners

Leerink Partners

$7.5

Hold

1.35%

Upside

Reiterated

07/30/25

Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures

Allen LutzBank of America Securities

Bank of America Securities

$8.75→$8.5

Hold

14.86%

Upside

Reiterated

07/30/25

Teladoc's Strategic Shift and Competitive Pressures Lead to Hold Rating

Charles RhyeeTD Cowen

TD Cowen

Hold

8.11%

Upside

Reiterated

07/30/25

Teladoc's Mixed Performance: Strong IC Growth Overshadowed by BH Segment Uncertainty Leading to Hold Rating

Elizabeth Anderson CFAEvercore ISI

Evercore ISI

$7→$8

Hold

8.11%

Upside

Reiterated

07/30/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC), Ionis Pharmaceuticals (NASDAQ: IONS) and Repligen (NASDAQ: RGEN)

Jailendra SinghTruist Financial

Truist Financial

―

Hold

―

Reiterated

07/30/25

Teladoc (TDOC) Gets a Hold from Truist Financial

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$12→$10

Buy

35.14%

Upside

Reiterated

07/29/25

Teladoc price target lowered to $10 from $12 at Cantor FitzgeraldTeladoc price target lowered to $10 from $12 at Cantor Fitzgerald

Ryan DanielsWilliam Blair

William Blair

―

Hold

―

Reiterated

07/29/25

Teladoc's Transitional Phase: Balancing Growth Challenges and Strategic Opportunities

Daniel GrosslightCiti

Citi

$8→$9.5

Hold

28.38%

Upside

Reiterated

07/28/25

Citi Keeps Their Hold Rating on Teladoc (TDOC)

Steven ValiquetteMizuho Securities

Mizuho Securities

$10

Hold

35.14%

Upside

Initiated

07/25/25

Teladoc's Mixed Prospects: Hold Rating Amid Growth in Integrated Care and Challenges in BetterHelp Segment

Jessica TassanPiper Sandler

Piper Sandler

$12

Buy

62.16%

Upside

Reiterated

07/18/25

Teladoc (TDOC) Receives a Buy from Piper Sandler

Lisa GillJ.P. Morgan

J.P. Morgan

$11→$9

Hold

21.62%

Upside

Reiterated

05/16/25

Teladoc (TDOC) PT Lowered to $9 at JPMorganJPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $9.00 (from $11.00) while maintaining a Neutral rating.

Stephen BaxterWells Fargo

Wells Fargo

$10→$8

Hold

8.11%

Upside

Reiterated

05/08/25

Teladoc (TDOC) PT Lowered to $8 at Wells FargoWells Fargo analyst Stephen Baxter lowered the price target on Teladoc (NYSE: TDOC) to $8.00 (from $10.00) while maintaining a Equal Weight rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Teladoc

1 Month

xxx

Success Rate

19/42 ratings generated profit

Average Return

-3.19%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 45.24% of your transactions generating a profit, with an average return of -3.19% per trade.

3 Months

xxx

Success Rate

26/48 ratings generated profit

Average Return

+2.01%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 54.17% of your transactions generating a profit, with an average return of +2.01% per trade.

1 Year

Richard CloseCanaccord Genuity

Success Rate

24/48 ratings generated profit

Average Return

+17.57%

reiterated a buy rating 3 months ago

Copying Richard Close's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +17.57% per trade.

2 Years

xxx

Success Rate

21/48 ratings generated profit

Average Return

+46.32%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 43.75% of your transactions generating a profit, with an average return of +46.32% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TDOC Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TDOC has received 2 Buy Ratings, 38 Hold Ratings, and 0 Sell Ratings. TDOC average Analyst price target in the past 3 months is 8.79.

Each month's total comprises the sum of three months' worth of ratings.

TDOC Financial Forecast

TDOC Earnings Forecast

Next quarter’s earnings estimate for TDOC is -$0.25 with a range of -$0.34 to -$0.10. The previous quarter’s EPS was -$0.19. TDOC beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.11% of the time in the same period. In the last calendar year TDOC has Preformed in-line its overall industry.

TDOC Sales Forecast

Next quarter’s sales forecast for TDOC is $626.51M with a range of $620.00M to $631.90M. The previous quarter’s sales results were $631.90M. TDOC beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.31% of the time in the same period. In the last calendar year TDOC has Preformed in-line its overall industry.

TDOC Stock Forecast FAQ

What is TDOC’s average 12-month price target, according to analysts?

Based on analyst ratings, Teladoc’s 12-month average price target is 8.79.

What is TDOC’s upside potential, based on the analysts’ average price target?

Teladoc has 18.78% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TDOC a Buy, Sell or Hold?

Teladoc has a consensus rating of Hold which is based on 2 buy ratings, 13 hold ratings and 0 sell ratings.

What is Teladoc’s price target?

The average price target for Teladoc is 8.79. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $7.00. The average price target represents 18.78% Increase from the current price of $7.4.

What do analysts say about Teladoc?

Teladoc’s analyst rating consensus is a Hold. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of TDOC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Teladoc (TDOC) Stock Forecast & Price Target

TDOC Analyst Ratings

TDOC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Teladoc

TDOC Analyst Recommendation Trends

TDOC Financial Forecast

TDOC Earnings Forecast

TDOC Sales Forecast

TDOC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts